Ziprasidone, monoamine oxidase inhibitors, and the serotonin syndrome

Journal of Clinical Psychopharmacology

Volumn 30, Issue 4, 2010, Pages 470-471

  Rim, Christina L ^a   Gitlin, Michael J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; DULOXETINE; FLUDROCORTISONE; LORAZEPAM; METHYLPHENIDATE; MONOAMINE OXIDASE INHIBITOR; SEROTONIN RECEPTOR; TRANYLCYPROMINE; ZIPRASIDONE; PIPERAZINE DERIVATIVE; SEROTONIN ANTAGONIST; THIAZOLE DERIVATIVE;

ADULT; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; CONFUSION; DIAPHORESIS; DIARRHEA; DIZZINESS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; FEMALE; FEVER; HIGH SODIUM INTAKE; HUMAN; INSOMNIA; LETTER; MAJOR DEPRESSION; PALLIATIVE THERAPY; PRIORITY JOURNAL; SEROTONIN SYNDROME; SHIVERING; SIDE EFFECT; TREMOR; VOMITING; CHEMICALLY INDUCED; DEPRESSIVE DISORDER, MAJOR; DRUG INTERACTION;

ADULT; DEPRESSIVE DISORDER, MAJOR; DRUG INTERACTIONS; FEMALE; HUMANS; MONOAMINE OXIDASE INHIBITORS; PIPERAZINES; SEROTONIN ANTAGONISTS; SEROTONIN SYNDROME; THIAZOLES; TRANYLCYPROMINE;

EID: 77955150783     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3181e63033     Document Type: Letter

References (17)

1. Philip NS, Carpenter LL, Tyrka AR, et al. Augmentation of antidepressants with atypical antipsychotics: a review of the current literature. J Psychiatric Pract. 2008;14:34-44.
2. Papakostas GI, Shelton RC, Smith J, et al. Augmentation of antidepressants with atypical antipsychotic medications for treatment-resistant major depressive disorder: a meta-analysis. J Clin Psychiatry. 2007;68:826-831.
3. Richelson E, Souder T. Binding of antipsychotic drugs to human brain receptors. Focus on newer generation compounds. Life Sci. 2000;68:29-39.
4. Duggal HS, Fetchko J. Serotonin syndrome and atypical antipsychotics. Am J Psychiatry. 2002;159:672-673.
5. Boyer ER, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352:112-120.
6. Sternbach HS. The serotonin syndrome. Am J Psychiatry. 1991;148:705-713.
7. Dunkley EJ, Isbister GK, Sibbritt D, et al. The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM. 2003;96:635-642.
8. Gillman PK. A review of serotonin toxicity data: implications for the mechanisms of antidepressant drug action. Biol Psychiatry. 2006;59(11):1046- 1051.
9. Isbister GK, Buckley NA, Whyte IM. Serotonin toxicity: a practical approach to diagnosis and treatment. Med J Aust. 2007;187(6):361-365.
10. Stanford SC, Stanford BJ, Gillman PK. Risk of severe serotonin toxicity following co-administration of methylene blue and serotonin reuptake inhibitors: an update on a case report of post-operative delirium. J Psychopharmacol (Oxf). 2009:1-6.
11. Isbister GK, Hackett LP, Dawson LH, et al. Moclobemide poisoning: toxicokinetics and occurrence of serotonin toxicity. Br J Pharmacol. 2003;56:441-450.
12. Whyte IM. Monoamine oxidase inhibitors. In: Dart RC, ed. Medical Toxicology. Baltimore, MD: Lippincott Williams & Wilkins; 2004:823-834.
13. Whyte IM. Serotonin toxicity (syndrome). In: Dart RC, ed. Medical Toxicology. Baltimore, MD: Lippincott Williams & Wilkins; 2004:103-106.
14. Nisijima K, Shioda K, Yoshino T, et al. Diazepam and chlormethiazole attenuate the development of hyperthermia in an animal model of the serotonin syndrome. Neurochem Int. 2003;43:155-164.
15. Shioda K, Nisihima K, Yoshinto T, et al. Extracellular serotonin, dopamine, and glutamate levels are elevated in the hypothalamus in a serotonin syndrome animal model induced by tranylcypromine and fluoxetine. Prog Neuropsychopharmacol Biol Psychiatry. 2004;28:633-640.
16. Lattanzi L, Danesi R, Lastella M, et al. Serotonin syndrome and the T102 9C polymorphism of the 5-HT2A receptor: a case report. Bipolar Disord. 2008;10(5) 655-656
17. Schmidt AW, Lebel LA, Howard HR Jr, et al. Ziprasidone: a novel antipsychotic with a unique human receptor binding profile. Eur J Pharmacol. 2001;425:197-201.